2026 Global: Abdominal Aortic Stent Graft System (Aaa Stent Graft System) Market -Competitive Review (2032) report
Description
The 2026 Global: Abdominal Aortic Stent Graft System (Aaa Stent Graft System) Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for abdominal aortic stent graft system (aaa stent graft system) market by geography and historical trend. The scope of the report extends to sizing of the abdominal aortic stent graft system (aaa stent graft system) market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Cook Medical, W.L. Gore & Associates, Cardinal Health, and Becton Dickinson dominate the Abdominal Aortic Stent Graft System market, commanding over 85% share through innovative endovascular devices for aneurysm repair. These leaders, alongside Endologix, Terumo Corporation, Artivion (CryoLife), MicroPort Scientific, and Lombard Medical, drive growth via advanced designs enhancing flexibility, sealability, and patient outcomes in EVAR procedures. Medtronic holds 33.5% market share with systems like the Endurant and AneuRx, enabling minimally invasive AAA treatments with reduced complications and faster recovery. Cook Medical captures 15.3% by offering customized Zenith grafts tailored to patient anatomy, boosting procedural success and long-term durability.
W.L. Gore & Associates excels with the EXCLUDER AAA Endoprosthesis, prioritizing biocompatible materials for superior sealing and flexibility in complex aneurysms. This innovation addresses high AAA prevalence, particularly in aging populations, supported by North America's advanced infrastructure and reimbursements. Cardinal Health (22.3% share) and Becton Dickinson (14.0%) advance delivery systems and vascular access, integrating polymer sealing for next-generation EVAR. Endologix innovates with ALTO and AFX2 systems, featuring adaptive rings for diverse anatomies and CE Mark approvals under EU regulations. Terumo Corporation emphasizes precision in products like Thoraflex Hybrid, expanding endovascular reliability amid rising cardiovascular burdens.
Artivion (5.1% share) leverages synthetic grafts for dissections, while MicroPort's Minos system achieved RMB 75 million sales in 2022 across 500 hospitals. Lombard Medical and others like Jotec focus on branched endografts for challenging cases, fueling 4.1-6.2% CAGR through R&D and global expansions. Market leaders invest in trials for fenestrated designs, countering open surgery limitations and tapping Asia-Pacific growth via infrastructure upgrades. This competitive landscape, dominated by U.S.-Ireland-Japan firms, projects the sector from $3.98 billion in 2025 to $8.29 billion by 2035.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for abdominal aortic stent graft system (aaa stent graft system) market by geography and historical trend. The scope of the report extends to sizing of the abdominal aortic stent graft system (aaa stent graft system) market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Cook Medical, W.L. Gore & Associates, Cardinal Health, and Becton Dickinson dominate the Abdominal Aortic Stent Graft System market, commanding over 85% share through innovative endovascular devices for aneurysm repair. These leaders, alongside Endologix, Terumo Corporation, Artivion (CryoLife), MicroPort Scientific, and Lombard Medical, drive growth via advanced designs enhancing flexibility, sealability, and patient outcomes in EVAR procedures. Medtronic holds 33.5% market share with systems like the Endurant and AneuRx, enabling minimally invasive AAA treatments with reduced complications and faster recovery. Cook Medical captures 15.3% by offering customized Zenith grafts tailored to patient anatomy, boosting procedural success and long-term durability.
W.L. Gore & Associates excels with the EXCLUDER AAA Endoprosthesis, prioritizing biocompatible materials for superior sealing and flexibility in complex aneurysms. This innovation addresses high AAA prevalence, particularly in aging populations, supported by North America's advanced infrastructure and reimbursements. Cardinal Health (22.3% share) and Becton Dickinson (14.0%) advance delivery systems and vascular access, integrating polymer sealing for next-generation EVAR. Endologix innovates with ALTO and AFX2 systems, featuring adaptive rings for diverse anatomies and CE Mark approvals under EU regulations. Terumo Corporation emphasizes precision in products like Thoraflex Hybrid, expanding endovascular reliability amid rising cardiovascular burdens.
Artivion (5.1% share) leverages synthetic grafts for dissections, while MicroPort's Minos system achieved RMB 75 million sales in 2022 across 500 hospitals. Lombard Medical and others like Jotec focus on branched endografts for challenging cases, fueling 4.1-6.2% CAGR through R&D and global expansions. Market leaders invest in trials for fenestrated designs, countering open surgery limitations and tapping Asia-Pacific growth via infrastructure upgrades. This competitive landscape, dominated by U.S.-Ireland-Japan firms, projects the sector from $3.98 billion in 2025 to $8.29 billion by 2035.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.